Something you can do NOW about the cost of care and “financial toxicities”

In an article in the October 25 issue of The ASCO Post, Dr. Jonas de Souza of the University of Chicago has introduced a new initiative to help all cancer patients and their doctors address the increasing problems associated with the costs of cancer care. … READ MORE …

How abiraterone acetate actually works in advanced prostate cancer

A regular reader of this column asked us to provide a “layman’s summary” of how the investigational drug abiraterone acetate actually works to delay the progression of metastatic, castration-resistant prostate cancer (mCRPC). So here you go … READ MORE …